University Hospital Florence presented at the ESTRO meeting the first international study supporting the clinical benefits of the Sentinel system.
Press release 2010-09-21
University Hospital Florence presented at the ESTRO meeting the first international study supporting the clinical benefits of the Sentinel system. C-RAD AB with its three fully owned subsidiaries are all active in the field of radiation therapy. The company attended the European oncology and physics meeting ESTRO in Barcelona, Spain, 12-16 September 2010. The GEMini ED and Sentinel with new functionality and features were presented in the C-RAD booth. The Sentinel and GEMini systems were presented in the C-RAD booth at ESTRO meeting 2010 in Barcelona. The main attraction was the new functionality for respiratory gating presented on a movable couch. A Sentinel system was also exhibited in the booth of the Swedish company Oncolog Medical. In March 2009 the first international study of the Sentinel system started at the University Hospital of Florence, Italy. The results were presented at the meeting in Barcelona. Data from an Elekta Synergy machine were compared with Sentinel data. Positioning with the Sentinel system was accurate and of high quality. An abstract of the report was distributed to all visitors. Prior to the ESTRO conference a first C-RAD European distributor´s meeting took place. The distributors were informed about new functionality and trained on the systems. Erik Hedlund, CEO, C-RAD AB: “The ESTRO 2010 conference confirmed the benefits of the C-RAD Sentinel and GEMini systems. The C-RAD team was from early in the mornings until late in the evenings very busy with presentations for clinicians coming from clinics in Europe, negotiations and discussions with partners and training of distributors. Both new projects and projects in its final stage were negotiated.” For further information: Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se About C-RAD AB C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 19 people. The activities in C-RAD AB originate from research and development at the Karolinska Institutet in Solna. Sales of the company's first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with the Swedish company Elekta and the Belgian company IBA. C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD AB is since March 2010 listed at Nasdaq Omx First North Premier.